Advertisement
Canada markets close in 1 hour 46 minutes

  • S&P/TSX

    21,987.16
    +101.78 (+0.47%)
     

  • S&P 500

    5,107.83
    +59.41 (+1.18%)
     

  • DOW

    38,313.54
    +227.74 (+0.60%)
     

  • CAD/USD

    0.7318
    -0.0005 (-0.07%)
     

  • CRUDE OIL

    83.91
    +0.34 (+0.41%)
     

  • Bitcoin CAD

    87,529.82
    -942.55 (-1.07%)
     

  • CMC Crypto 200

    1,331.90
    -64.63 (-4.63%)
     

  • GOLD FUTURES

    2,350.30
    +7.80 (+0.33%)
     

  • RUSSELL 2000

    2,004.00
    +22.89 (+1.16%)
     

  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     

  • NASDAQ

    15,935.63
    +323.87 (+2.07%)
     

  • VOLATILITY

    15.10
    -0.27 (-1.76%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6839
    +0.0018 (+0.26%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Latest stubborn U.S. inflation reading will bring about more 'wait and see' from the Fed

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of COTY, ODT and NXTC

ACCESSWIRE
·3 min read

NEW YORK, NY / ACCESSWIRE / October 23, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Coty Inc. (NYSE:COTY)

Investors Affected: October 3, 2016 - May 28, 2020

A class action has commenced on behalf of certain shareholders in Coty Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) despite being no stranger to beauty brand acquisitions, Coty did not have adequate processes and procedures in place to assess and properly value the P&G Specialty Beauty Business and Kylie Cosmetics acquisitions; (2) as a result, Coty had overpaid for the P&G Specialty Beauty Business and Kylie Cosmetics; (3) Coty did not have adequate infrastructure to smoothly integrate and support the beauty brands that it acquired from P&G, including an adequate supply chain; (4) as a result of its inadequate infrastructure, Coty was not successfully integrating the beauty brands it acquired from P&G and not delivering synergies from the acquisition; and (5) as a result of the foregoing, Coty's financial statements and Defendants' statements about Coty's business, operations, and prospects, were materially false and/or misleading at all relevant times.

ADVERTISEMENT

Shareholders may find more information at https://securitiesclasslaw.com/securities/coty-inc-loss-submission-form/?id=10436&from=1

Odonate Therapeutics, Inc. (NASDAQ:ODT)

Investors Affected: December 7, 2017 - April 21, 2020

A class action has commenced on behalf of certain shareholders in Odonate Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's orally administered chemotherapy agent, tesetaxel, was not as safe or well-tolerated as the Company had led investors to believe; (ii) consequently, tesetaxel's commercial viability as a cancer treatment was overstated; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/odonate-therapeutics-inc-loss-submission-form/?id=10436&from=1

Nextcure, Inc. (NASDAQ:NXTC)

The Nextcure lawsuit was filed on behalf of investors who purchased Nextcure, Inc. (NASDAQ: NXTC) securities: (1) between November 5, 2019 and July 14, 2020, inclusive; and/or (2) pursuant or traceable to the company's secondary public offering declared effective on November 14, 2019.

A class action has commenced on behalf of certain shareholders in Nextcure, Inc. Throughout the class period defendants' statements were materially misleading because the data Defendants possessed on its principle product candidate, NC318, showed a lack of efficacy and objective responses. Had the truth been revealed, the market would have seen that NC318 was not, in fact, effective in treating most tumor types, that the NC318 application was proving to be limited (if even useful at all), and, as a result, there was a significant realizable risk that NC318 would not be nearly as popular as then-existing blockbuster drugs, such as Keytruda.

Shareholders may find more information at https://securitiesclasslaw.com/securities/nextcure-inc-loss-submission-form/?id=10436&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/612057/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-COTY-ODT-and-NXTC